Document is current
Any future updates will be listed below
-
Authors
Anekalla, Thirupathi Reddy https://orcid.org/0009-0000-6671-1188
Bashetty, Sujith Raj https://orcid.org/0009-0002-8987-3870
Nalajala, Navya https://orcid.org/0009-0000-1887-2999
Narala, Nagarjuna https://orcid.org/0009-0002-1324-3661
Appidi, Tejaswi https://orcid.org/0009-0005-9243-5101
Chakka, LR Jaidev https://orcid.org/0000-0003-0039-0064
Maniruzzaman, Mohammed https://orcid.org/0000-0002-3373-5586
- License Information
-
More Information
Article History
Received: 30 March 2026
Accepted: 30 June 2026
First Online: 9 September 2026
Declarations
Conflict of interest: Dr. Mohammed Maniruzzaman holds stock in, serves on a scientific advisory board for, or is a consultant for CoM3D (Surrey, UK), DosePlus Therapeutics (Princeton, NJ, USA), Septum Solutions (Houston, TX, USA), and SmarGic Tech LLC (Oxford, MS, USA). The companies had no role in the design of the study, in the collection, analysis, or interpretation of data. L.R. Jaidev Chakka holds stock in SmarGic Tech LLC.
